0001399529-21-000164.txt : 20211214 0001399529-21-000164.hdr.sgml : 20211214 20211214210221 ACCESSION NUMBER: 0001399529-21-000164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211213 FILED AS OF DATE: 20211214 DATE AS OF CHANGE: 20211214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ciappenelli Robert D. CENTRAL INDEX KEY: 0001778786 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 211492697 MAIL ADDRESS: STREET 1: DICERNA PHARMACEUTICALS, INC. STREET 2: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205993609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 wf-form4_163953372606162.xml FORM 4 X0306 4 2021-12-13 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001778786 Ciappenelli Robert D. C/O DICERNA PHARMACEUTICALS, INC. 75 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Strategy Officer Common Stock 2021-12-13 4 M 0 8856 22.58 A 12629 D Employee Stock Option (Right to Buy) 22.58 2021-12-13 4 M 0 8856 0 D 2030-01-07 Common Stock 8856.0 76144 D The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2020, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the reporting person's continued service with the issuer through each applicable vesting date. /s/ Douglas W. Pagan, attorney-in-fact 2021-12-14